Join to invest

Already registered? Log in

317%
Raised
£953,990
Investors
1290
Target
£300,000

Convertible round

Rather than investing and immediately receiving shares, in this round payments will be transferred directly to the company and shares issued at a future date. A convertible allows a company to raise funds without having to agree a valuation. For more information please view our FAQs.

FreeHand is a robotic surgical camera controller that provides rock-steady images and precise control saving time and improving outcomes. With regulatory approval in the EU, US and Japan, Freehand is fundraising to support sales growth.

  • The market for surgical robotics is expected to reach $91.5B by 2025
  • FreeHand has regulatory clearance for sale in the EU, US and Japan
  • Surgeons have successfully used FreeHand in >15,000 procedures
  • >12M applicable procedures happen every year

Idea

Over 15 million keyhole surgeries are performed annually. Common procedures include appendectomies, gall bladder removal, hernia repair and cancer treatment. Most of these require an additional clinician in theatre to manually hold the camera the surgeon uses to see the operating field.

Anyone who has seen a shaky cell-phone video knows that holding objects steady for long periods of time is not something humans do well. Hand-held surgical cameras produce sub-optimal images with shake, drift and rotation. The patented FreeHand robotic camera controller provides a clear, rock steady image giving the surgeon full and precise control.

Studies show that FreeHand can REDUCE:

* Operating time by up to 20%

* Post-operative recovery time and complications

* Surgical training time

* Theatre head-count

Surgical robotics is one of the fastest-growing segments in MedTech, projected to reach $91.5B by 2025. FreeHand provides hospitals with an affordable, easy-to-use platform to realise the benefits of robotic assistance in operating rooms.

With the hiring of an experienced VP of Sales in May of 2019 and the launch of Freehand Panorama, the company now has hospitals and distributors signed up in the UK, Spain, Netherlands and Italy.

This investment will fund expansion of distributor base in Europe, Asia and Latin America, targeting over 12 million procedures annually.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Freehand pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated. Please click here to read the full Risk Warning.

Crowdcube is authorised and regulated by the Financial Conduct Authority (FCA) and the Comisión Nacional del Mercado de Valores (CNMV). This page has been approved by Crowdcube. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Freehand has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.